心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

沙库巴曲缬沙坦钠在基层心血管疾病临床应用的专家共识

2021-06-28 中国医师协会全科医师分会 中国全科医学. 2021,24(23)

沙库巴曲缬沙坦

沙库巴曲缬沙坦钠作为全球首个血管紧张素受体脑啡肽酶抑制剂类药物,在治疗心力衰竭和高血压方面疗效确切且安全性良好,同时在急性心肌梗死及心律失常等心血管疾病中表现出潜在的治疗效果。由于沙库巴曲缬沙坦钠在我

中文标题：

沙库巴曲缬沙坦钠在基层心血管疾病临床应用的专家共识

发布机构：

中国医师协会全科医师分会

发布日期：

2021-06-28

简要介绍：

沙库巴曲缬沙坦钠作为全球首个血管紧张素受体脑啡肽酶抑制剂类药物,在治疗心力衰竭和高血压方面疗效确切且安全性良好,同时在急性心肌梗死及心律失常等心血管疾病中表现出潜在的治疗效果。由于沙库巴曲缬沙坦钠在我国上市时间不长,目前临床医生,特别是基层全科医生对该药的临床应用经验较少,故中国医师协会全科医师分会组织14位心血管内科、全科医学领域的专家,基于循证医学证据和国内外相关指南、共识,结合基层的临床实际制定《沙库巴曲缬沙坦钠在基层心血管疾病临床应用的专家共识》,主要包括沙库巴曲缬沙坦钠的药理学特点与作用机制、循证医学证据和相关指南推荐及临床应用方法,以期指导基层全科医生合理规范化应用沙库巴曲缬沙坦钠。 
 

相关资料下载：
[AttachmentFileName(sort=1, fileName=沙库巴曲缬沙坦钠在基层心血管疾病临床应用的专家共识_杜雪平.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2bbe71c002128863, title=沙库巴曲缬沙坦钠在基层心血管疾病临床应用的专家共识 , enTitle=, guiderFrom=中国全科医学. 2021,24(23), authorId=0, author=, summary=沙库巴曲缬沙坦钠作为全球首个血管紧张素受体脑啡肽酶抑制剂类药物,在治疗心力衰竭和高血压方面疗效确切且安全性良好,同时在急性心肌梗死及心律失常等心血管疾病中表现出潜在的治疗效果。由于沙库巴曲缬沙坦钠在我, cover=https://img.medsci.cn/2021715/1626283896115_2020535.jpg, journalId=0, articlesId=null, associationId=1581, associationName=中国医师协会全科医师分会, associationIntro= , copyright=0, guiderPublishedTime=Mon Jun 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">沙库巴曲缬沙坦钠作为全球首个血管紧张素受体脑啡肽酶抑制剂类药物,在治疗心力衰竭和高血压方面疗效确切且安全性良好,同时在急性心肌梗死及心律失常等心血管疾病中表现出潜在的治疗效果。由于沙库巴曲缬沙坦钠在我国上市时间不长,目前临床医生,特别是基层全科医生对该药的临床应用经验较少,故中国医师协会全科医师分会组织14位心血管内科、全科医学领域的专家,基于循证医学证据和国内外相关指南、共识,结合基层的临床实际制定《沙库巴曲缬沙坦钠在基层心血管疾病临床应用的专家共识》,主要包括沙库巴曲缬沙坦钠的药理学特点与作用机制、循证医学证据和相关指南推荐及临床应用方法,以期指导基层全科医生合理规范化应用沙库巴曲缬沙坦钠。&nbsp;</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=69642, tagName=沙库巴曲缬沙坦)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=69642, guiderKeyword=沙库巴曲缬沙坦, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3512, appHits=228, showAppHits=0, pcHits=763, showPcHits=3281, likes=1, shares=17, comments=9, approvalStatus=1, publishedTime=Thu Jul 15 01:51:49 CST 2021, publishedTimeString=2021-06-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 15 01:31:41 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 15:30:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=沙库巴曲缬沙坦钠在基层心血管疾病临床应用的专家共识_杜雪平.pdf)])
沙库巴曲缬沙坦钠在基层心血管疾病临床应用的专家共识_杜雪平.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1080540, encodeId=b7f610805406c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:40:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080536, encodeId=546010805363f, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:39:03 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057568, encodeId=f168105e568da, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:12 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012388, encodeId=40ea1012388e0, content=今年刚推高血压适应症。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:55 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012387, encodeId=1f10101238e64, content=这么快就推到基层了，医保报销不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:16 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-12-16 龙珠

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1080540, encodeId=b7f610805406c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:40:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080536, encodeId=546010805363f, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:39:03 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057568, encodeId=f168105e568da, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:12 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012388, encodeId=40ea1012388e0, content=今年刚推高血压适应症。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:55 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012387, encodeId=1f10101238e64, content=这么快就推到基层了，医保报销不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:16 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-12-16 龙珠

    学习好资料

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1080540, encodeId=b7f610805406c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:40:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080536, encodeId=546010805363f, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:39:03 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057568, encodeId=f168105e568da, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:12 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012388, encodeId=40ea1012388e0, content=今年刚推高血压适应症。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:55 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012387, encodeId=1f10101238e64, content=这么快就推到基层了，医保报销不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:16 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1080540, encodeId=b7f610805406c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:40:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080536, encodeId=546010805363f, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:39:03 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057568, encodeId=f168105e568da, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:12 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012388, encodeId=40ea1012388e0, content=今年刚推高血压适应症。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:55 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012387, encodeId=1f10101238e64, content=这么快就推到基层了，医保报销不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:16 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-08-28 门一僧

    今年刚推高血压适应症。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1080540, encodeId=b7f610805406c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:40:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080536, encodeId=546010805363f, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 08:39:03 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057568, encodeId=f168105e568da, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:12 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012388, encodeId=40ea1012388e0, content=今年刚推高血压适应症。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:55 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012387, encodeId=1f10101238e64, content=这么快就推到基层了，医保报销不, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4b5411107, createdName=门一僧, createdTime=Sat Aug 28 20:24:16 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-08-28 门一僧

    这么快就推到基层了，医保报销不

    0